These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 19052878)
21. Manipulation of microglial activity as a therapy for Alzheimer's disease. Tan B; Choi RH; Chin TJ; Kaur C; Ling EA Front Biosci (Schol Ed); 2012 Jun; 4(4):1402-12. PubMed ID: 22652882 [TBL] [Abstract][Full Text] [Related]
22. Microglial phagocytosis in aging and Alzheimer's disease. Gabandé-Rodríguez E; Keane L; Capasso M J Neurosci Res; 2020 Feb; 98(2):284-298. PubMed ID: 30942936 [TBL] [Abstract][Full Text] [Related]
24. Mitochondrial Regulation of Microglial Immunometabolism in Alzheimer's Disease. Fairley LH; Wong JH; Barron AM Front Immunol; 2021; 12():624538. PubMed ID: 33717134 [TBL] [Abstract][Full Text] [Related]
25. TSPO deficiency accelerates amyloid pathology and neuroinflammation by impairing microglial phagocytosis. Zhang H; Wang H; Gao F; Yang J; Xu Y; Fu Y; Cai M; Zhang X; Yang Q; Tong K; Hu Y; Chen H; Ma C; He W; Zhang J Neurobiol Aging; 2021 Oct; 106():292-303. PubMed ID: 34340010 [TBL] [Abstract][Full Text] [Related]
29. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease. Webers A; Heneka MT; Gleeson PA Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430 [TBL] [Abstract][Full Text] [Related]
30. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease. Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049 [TBL] [Abstract][Full Text] [Related]
31. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Liu Y; Walter S; Stagi M; Cherny D; Letiembre M; Schulz-Schaeffer W; Heine H; Penke B; Neumann H; Fassbender K Brain; 2005 Aug; 128(Pt 8):1778-89. PubMed ID: 15857927 [TBL] [Abstract][Full Text] [Related]
32. Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease. Janssen B; Mach RH Prog Mol Biol Transl Sci; 2019; 165():371-399. PubMed ID: 31481170 [TBL] [Abstract][Full Text] [Related]
33. Evaluating the Role of Microglial Cells in Clearance of Aβ from Alzheimer's Brain. Manchikalapudi AL; Chilakala RR; Kalia K; Sunkaria A ACS Chem Neurosci; 2019 Mar; 10(3):1149-1156. PubMed ID: 30609357 [TBL] [Abstract][Full Text] [Related]
34. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers. Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448 [TBL] [Abstract][Full Text] [Related]
35. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease. Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396 [TBL] [Abstract][Full Text] [Related]
36. Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein. Ji B; Ono M; Yamasaki T; Fujinaga M; Zhang MR; Seki C; Aoki I; Kito S; Sawada M; Suhara T; Sahara N; Higuchi M J Cereb Blood Flow Metab; 2021 Aug; 41(8):2076-2089. PubMed ID: 33557690 [TBL] [Abstract][Full Text] [Related]
37. Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. Lopes KO; Sparks DL; Streit WJ Glia; 2008 Aug; 56(10):1048-60. PubMed ID: 18442088 [TBL] [Abstract][Full Text] [Related]
39. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease. Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846 [TBL] [Abstract][Full Text] [Related]
40. The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models. Ma QL; Zhu C; Morselli M; Su T; Pelligrini M; Lu Z; Jones M; Denver P; Castro D; Gu X; Relampagos F; Caoili K; Teter B; Frautschy SA; Cole GM Front Immunol; 2020; 11():558036. PubMed ID: 33178186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]